FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Trastuzumab 150 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Trastuzumab 150 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Pentostatin 10 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pentostatin 10 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely meropenem (as meropenem trihydrate) 500 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely meropenem (as meropenem trihydrate) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Hyaluronidase 1500 unit powder for solution for injection ampule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Hyaluronidase 1500 unit powder for solution for injection ampule Count of base of active ingredient False 1 Inferred relationship Some
    Mitomycin 2 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mitomycin 2 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Neomycin sulfate 25 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Infliximab 100 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Infliximab 100 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Imiglucerase 200 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Imiglucerase 200 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Gabapentin 50 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Chlorpromazine hydrochloride 5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cimetidine 40 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Cimetidine 40 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefprozil 50 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefprozil 50 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefalexin 100 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefalexin 100 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cefradine 50 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Cefradine 50 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Chloral hydrate 28.6 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Chloral hydrate 28.6 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 50 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 50 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 50 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 73 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start